Repare Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Repare Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RPTX | Repare Therapeutics | -$0.81 | -$0.27 | — | — | $0.00 | $6.50M | — | — | 11/06/2025 | |
RPTX | Repare Therapeutics | -$0.82 | -$0.56 | -$0.39 | 30.36% | $1.07M | $3.00M | $250.00K | -91.67% | 08/08/2025 | |
RPTX | Repare Therapeutics | $0.30 | -$0.62 | -$0.71 | -14.52% | $52.40M | $1.25M | $0.00 | -100.00% | 05/13/2025 | |
RPTX | Repare Therapeutics | -$0.67 | -$0.79 | -$0.67 | 15.19% | $13.05M | $2.73M | $0.00 | -100.00% | 03/03/2025 | |
RPTX | Repare Therapeutics | -$0.45 | -$0.87 | -$0.81 | 6.90% | $2.16M | $2.91M | $0.00 | -100.00% | 11/07/2024 | |
RPTX | Repare Therapeutics | -$0.28 | -$0.87 | -$0.82 | 5.75% | $30.25M | $2.92M | $1.07M | -63.30% | 08/06/2024 | |
RPTX | Repare Therapeutics | -$0.83 | $0.02 | $0.30 | 1400.00% | $5.68M | $38.40M | $52.40M | 36.47% | 05/07/2024 | |
RPTX | Repare Therapeutics | -$0.75 | -$0.46 | -$0.67 | -45.65% | $18.20M | $18.93M | $13.05M | -31.08% | 02/28/2024 | |
RPTX | Repare Therapeutics | $1.71 | -$0.86 | -$0.45 | 47.67% | $112.55M | $6.31M | $2.16M | -65.78% | 11/09/2023 | |
RPTX | Repare Therapeutics | -$0.91 | -$0.78 | -$0.28 | 64.10% | $679.00K | $7.68M | $30.25M | 293.87% | 08/09/2023 | |
RPTX | Repare Therapeutics | -$0.83 | -$0.81 | -$0.83 | -2.47% | $408.00K | $6.12M | $5.68M | -7.22% | 05/09/2023 | |
RPTX | Repare Therapeutics | -$0.70 | -$0.97 | -$0.75 | 22.68% | $6.88M | $10.83M | $18.20M | 68.03% | 02/28/2023 | |
RPTX | Repare Therapeutics | -$0.83 | -$0.89 | $1.71 | 292.13% | $278.00K | $1.58M | $112.55M | 7023.10% | 11/09/2022 | |
RPTX | Repare Therapeutics | -$0.71 | -$0.86 | -$0.91 | -5.81% | $279.00K | — | $679.00K | — | 08/04/2022 | |
RPTX | Repare Therapeutics | -$0.58 | -$0.86 | -$0.83 | 3.49% | $166.00K | $2.35M | $408.00K | -82.64% | 05/05/2022 | |
RPTX | Repare Therapeutics | -$0.41 | -$0.74 | -$0.70 | 5.41% | $135.00K | $3.28M | $6.88M | 109.66% | 03/01/2022 | |
RPTX | Repare Therapeutics | -$0.37 | — | -$0.83 | — | $0.00 | — | $278.00K | — | 11/10/2021 | |
RPTX | Repare Therapeutics | -$2.45 | -$0.60 | -$0.71 | -18.33% | $0.00 | $600.00K | $279.00K | -53.50% | 08/12/2021 | |
RPTX | Repare Therapeutics | — | -$0.58 | -$0.58 | 0.00% | — | $620.00K | $166.00K | -73.23% | 05/13/2021 | |
RPTX | Repare Therapeutics | -$5.45 | — | -$0.41 | — | — | — | $135.00K | — | 03/04/2021 | |
RPTX | Repare Therapeutics | -$5.03 | — | -$0.37 | — | — | — | $0.00 | — | 11/11/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-08 | $-0.39 | $-0.56 | 30.4 % |
Q1 | 2025-05-13 | $-0.71 | $-0.62 | -14.5 % |
Q4 | 2025-03-03 | $-0.67 | $-0.79 | 15.2 % |
Q3 | 2024-11-07 | $-0.81 | $-0.87 | 6.90 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-08 | $250.00K | $3.00M | -91.7 % |
Q1 | 2025-05-13 | $0 | $1.25M | -100.0 % |
Q4 | 2025-03-03 | $0 | $2.73M | -100.0 % |
Q3 | 2024-11-07 | $0 | $2.91M | -100.0 % |
Está previsto que Repare Therapeutics (RPTX) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 8, 2025 para el Q2.
El BPA real fue de $-0.39, que superó la estimación de $-0.56.
Los ingresos reales fueron $250K, que no alcanzó la estimación de $3M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.